These are the stocks that are passing at least three of my five filters, for the week of October 20. There were no IBD Supply/Demand stocks this week. There were only two stocks that were Top Ranked by the IBD.
Symbol | Top Ranked | Zacks | PEG | SuppDem | VL | IBD Stock checkup |
AMED | 1 | 1 | 1 | A+ | ||
ARO | 1 | 1 | 1 | A | ||
FLIR | 1 | 1 | 1 | A | ||
JOSB | 1 | 1 | 1 | A | ||
MATK | 1 | 1 | 1 | A |
CF and FSLR are off the list.
Core list (with n of 10 weeks passing):
Symbol | Passing weeks | Earnings |
ARO | 10 | Earn 3-Dec |
FLIR | 10 | Earn 23-Oct |
EZPW | 8 | Earn 6-Nov |
WAB | 8 | Earn 20-Oct |
CELG | 8 | Earn 23-Oct |
URBN | 7 | Earn 13-Nov |
AMED | 7 | Earn 28-Oct |
AXYS | 6 | Earn 22-Oct |
OSIP | 6 | Earn 22-Oct |
MANT | 5 | Earn 29-Oct |
VMI | 5 | |
moving down this week | |
moving up this week | |
new this week |
John Hussman, a mutual fund manager for whom I have a great deal of respect, says that stocks are no longer overvalued. Not urging us to run out and buy, he is saying that the long-term outlook is the best that it's been for some time, precisely because stocks have been hammered so badly.
I'm conflicted on the idea. I will keep my long/short balance and try to move in or out of long positions slowly.
No comments:
Post a Comment